Stockscreener 앱 받기
4.678
2.41%
0.108
전일 마감가:
$4.57
열려 있는:
$4.58
하루 거래량:
149.48K
Relative Volume:
0.36
시가총액:
$217.26M
수익:
$20.72M
순이익/손실:
$-100.84M
주가수익비율:
-1.7586
EPS:
-2.66
순현금흐름:
$-78.56M
1주 성능:
+10.38%
1개월 성능:
+21.87%
6개월 성능:
+0.65%
1년 성능:
-74.50%
1일 변동 폭
$4.5293
$4.75
1주일 범위
$4.21
$4.75
52주 변동 폭
$2.235
$18.38
4D몰큘러 테라퓨틱스 Stock (FDMT) Company Profile
명칭
4 D Molecular Therapeutics Inc
전화
(510) 505-2680
주소
5858 HORTON STREET #455, EMERYVILLE
FDMT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FDMT
4 D Molecular Therapeutics Inc
|
4.69 | 211.70M | 20.72M | -100.84M | -78.56M | -2.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
466.18 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.29 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.31 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
596.76 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
297.80 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
4D몰큘러 테라퓨틱스 Stock (FDMT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-13 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-11-21 | 개시 | Morgan Stanley | Underweight |
| 2024-09-23 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-04-15 | 개시 | Barclays | Overweight |
| 2024-02-07 | 재개 | Goldman | Buy |
| 2023-10-26 | 개시 | RBC Capital Mkts | Outperform |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-10-18 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | 개시 | Chardan Capital Markets | Buy |
| 2023-01-30 | 개시 | BMO Capital Markets | Outperform |
| 2022-11-18 | 개시 | H.C. Wainwright | Buy |
| 2022-11-15 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-08-12 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-06-22 | 개시 | Jefferies | Buy |
| 2022-01-04 | 개시 | SVB Leerink | Outperform |
| 2021-01-05 | 개시 | BofA Securities | Buy |
| 2021-01-05 | 개시 | Evercore ISI | Outperform |
| 2021-01-05 | 개시 | Goldman | Neutral |
모두보기
4D몰큘러 테라퓨틱스 주식(FDMT)의 최신 뉴스
Analyzing drawdowns of 4D Molecular Therapeutics Inc. with statistical toolsHigh Conviction Screener with Trend Matching - Newser
What makes 4D Molecular Therapeutics Inc. stock attractive to long term investors Free Opportunity Map for Daily Stock Trading - Newser
What catalysts could drive 4D Molecular Therapeutics Inc. stock higher in 2025Wealth Building Signals From AI Tools - jammulinksnews.com
What is the dividend policy of 4D Molecular Therapeutics Inc. stockSuperior portfolio returns - jammulinksnews.com
Is 4D Molecular Therapeutics Inc. stock overvalued or undervaluedMarket Forecast Insights For 2025 - jammulinksnews.com
How does 4D Molecular Therapeutics Inc. generate profit in a changing economyInvest confidently with actionable market data - jammulinksnews.com
What is 4D Molecular Therapeutics Inc. company’s growth strategyInvest smarter with data-backed insights - jammulinksnews.com
What are the technical indicators suggesting about 4D Molecular Therapeutics Inc.Unlock expert insights for smarter investing - jammulinksnews.com
Is 4D Molecular Therapeutics Inc. a growth stock or a value stockMarket-leading capital gains - jammulinksnews.com
Why is 4D Molecular Therapeutics Inc. stock attracting strong analyst attentionDiscover stocks with explosive potential - jammulinksnews.com
Sectors Driving Future Growth for 4D Molecular Therapeutics Inc. StockProven Trading Plan - Newser
Is 4D Molecular Therapeutics Inc. Stock a Good Fit for Conservative InvestorsTriple Digit Return Forecasts - Newser
What makes 4D Molecular Therapeutics Inc. stock attractive to long term investorsTop Momentum Stock Pick - Newser
Does 4D Molecular Therapeutics Inc. stock perform well during market downturnsStrong return on investment - jammulinksnews.com
Why 4D Molecular Therapeutics Inc. stock attracts strong analyst attentionBreakout Momentum Stocks - beatles.ru
What drives 4D Molecular Therapeutics Inc. stock priceRapidly expanding wealth - PrintWeekIndia
4D Molecular Therapeutics Inc. Stock Analysis and ForecastTremendous portfolio expansion - PrintWeekIndia
4DMT Announces Presentations at 43rd Annual Scientific Meeting of the American Society of Retina Specialists - GlobeNewswire
4DMT Announces Presentations at 43rd Annual Scientific Meeting of the American Society of Retina Specialists - GlobeNewswire Inc.
What analysts say about 4D Molecular Therapeutics Inc. stockUnrivaled growth potential - Autocar Professional
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives $29.56 Average Price Target from Analysts - Defense World
Is 4D Molecular Therapeutics Inc. a good long term investmentHigh-performance investment picks - jammulinksnews.com
Layoff Tracker: Following Challenges With DMD Therapy, Sarepta Will Cut 500 Employees - BioSpace
Top Stocks for Aggressive Investors Top Growth StocksUnrivaled growth potential - Jammu Links News
Fierce Biotech Layoff Tracker 2025: Sail shrinks crew again; Sarepta lays off 500 staffers - Fierce Biotech
4D Molecular Therapeutics’ Phase 3 Trial: A New Hope for Age-Related Macular Degeneration? - TipRanks
What makes 4D Molecular Therapeutics Inc. stock price move sharplyHigh Return Potential - Newser
How 4D Molecular Therapeutics Inc. stock performs during market volatilityAI Powered Stock Call - Newser
Weiss Ratings Reiterates “Sell (D-)” Rating for 4D Molecular Therapeutics (NASDAQ:FDMT) - Defense World
4DMT Announces New Employment Inducement Grants - GlobeNewswire
Late-Stage Biotech 4DMT Grants Significant RSU Package in Latest Strategic Hire - Stock Titan
4D몰큘러 테라퓨틱스 (FDMT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.49%
1.16%
자본화:
|
볼륨(24시간):